References
- Halpern J. From Detached Concern to Empathy: Humanizing Medical Practice. New York, NY: Oxford University Press; 2001.
- Greenhalgh T, Hurwitz B. Narrative based medicine: why study narrative? BMJ. 1999;318(7175):48–50. doi:10.1136/bmj.318.7175.48
- Doward LC, Gnanasakthy A, Baker MG. Patient reported outcomes: looking beyond the label claim. Health Qual Life Outcomes. 2010;8:89. doi:10.1186/1477-7525-8-89
- Hareendran A, Gnanasakthy A, Winnette R, Revicki D. Capturing patients’ perspectives of treatment in clinical trials/drug development. Contemp Clin Trials. 2012;33(1):23–28. doi:10.1016/j.cct.2011.09.015
- Messina J, Grainger DL. A pilot study to identify areas for further improvements in patient and public involvement in health technology assessments for medicines. Patient. 2012;5(3):199–211.
- Wagland R, Recio-Saucedo A, Simon M, et al. Development and testing of a text-mining approach to analyse patients’ comments on their experiences of colorectal cancer care. BMJ Qual Saf. 2016;25(8):604–614. doi:10.1136/bmjqs-2015-004063
- Weaver M, Patrick DL, Markson LE, et al. Issues in the measurement of satisfaction with treatment. Am J Manag Care. 1997;3(4):579–594.
- Regnault A, Balp MM, Kulich K, Viala-Danten M. Validation of the treatment satisfaction questionnaire for medication in patients with cystic fibrosis. J Cyst Fibros. 2012;11(6):494–501. doi:10.1016/j.jcf.2012.04.007
- Reaney M, Bush E, New M, et al. The potential role of individual-level benefit-risk assessment in treatment decision making: a DIA study endpoints community workstream. Ther Innov Regul Sci. 2019;53(5):630–638. doi:10.1177/2168479018807448
- Edwards P. Questionnaires in clinical trials: guidelines for optimal design and administration. Trials. 2010;11:2. doi:10.1186/1745-6215-11-2
- Falissard B, Simpson EL, Guttman-Yassky E, et al. Qualitative assessment of adult patients’ perception of atopic dermatitis using natural language processing analysis in a cross-sectional study. Dermatol Ther (Heidelb). 2020;10(2):297–305. doi:10.1007/s13555-020-00356-0
- Abbe A, Grouin C, Zweigenbaum P, Falissard B. Text mining applications in psychiatry: a systematic literature review. Int J Methods Psychiatr Res. 2016;25(2):86–100. doi:10.1002/mpr.1481
- Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1–464. doi:10.4193/Rhin20.401
- Khan A, Huynh TMT, Vandeplas G, et al. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology. 2019;57(5):343–351.
- Palmer JN, Messina JC, Biletch R, et al. A cross-sectional, population-based survey of US adults with symptoms of chronic rhinosinusitis. Allergy Asthma Proc. 2019;40(1):48–56. doi:10.2500/aap.2019.40.4182
- Bhattacharyya N, Villeneuve S, Joish VN, et al. Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope. 2019;129(9):1969–1975. doi:10.1002/lary.27852
- Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;14:127–134. doi:10.2147/JAA.S290424
- Oyer SL, Mulligan JK, Psaltis AJ, et al. Cytokine correlation between sinus tissue and nasal secretions among chronic rhinosinusitis and controls. Laryngoscope. 2013;123(12):E72–E78. doi:10.1002/lary.24305
- Miljkovic D, Bassiouni A, Cooksley C, et al. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy. 2014;69(9):1154–1161. doi:10.1111/all.12440
- Macdonald LE, Karow M, Stevens S, et al. Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes. Proc Natl Acad Sci U S A. 2014;111(14):5147–5152. doi:10.1073/pnas.1323896111
- Murphy AJ, Macdonald LE, Stevens S, et al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci U S A. 2014;111(14):5153. doi:10.1073/pnas.1324022111
- Gandhi NA, Pirozzi G, Graham NMH. Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert Rev Clin Immunol. 2017;13(5):425–437. doi:10.1080/1744666X.2017.1298443
- DUPIXENT® (dupilumab) injection [prescribing information]. Bridgewater, NJ; Tarrytown, NY: Sanofi-Aventis U.S. LLC; Regeneron Pharmaceuticals, Inc.; 2019.
- DUPIXENT® (dupilumab) injection [summary of product characteristics]. Paris, France: Sanofi-Aventis Groupe; 2017.
- Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315(5):469–479. doi:10.1001/jama.2015.19330
- Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group Phase 3 trials. Lancet. 2019;394(10209):1638–1650. doi:10.1016/S0140-6736(19)31881-1
- Bachert C, Hellings PW, Mullol J, et al. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020;75(1):148–157. doi:10.1111/all.13984
- Locke S, Bashall A, Al-Adely S, et al. Natural language processing in medicine: a review. Trends Anaesth Crit Care. 2021;38:4–9. doi:10.1016/j.tacc.2021.02.007
- de Hollander G, Marx M. Summarization of meetings using word clouds. In computer science and software engineering (CSSE). Paper presented at: CSI International Symposium 2011. IEEE; 2011:54–61.
- Newman ME. Fast algorithm for detecting community structure in networks. Phys Rev E Stat Nonlin Soft Matter Phys. 2004;69(6 Pt 2):066133. doi:10.1103/PhysRevE.69.066133
- Clauset A, Newman MEJ, Moore C. Finding community structure in very large networks. Phys Rev E. 2004;70(6):066111. doi:10.1103/PhysRevE.70.066111
- Levy JM, Mace JC, Bodner TE, et al. Defining the minimal clinically important difference for olfactory outcomes in the surgical treatment of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7(8):821–826. doi:10.1002/alr.21964
- Sindwani R, Han JK, Soteres DF, et al. Navigate i: randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 2019;33(1):69–82. doi:10.1177/1945892418810281
- Ricci-Cabello I, Saletti-Cuesta L, Slight SP, Valderas JM. Identifying patient-centred recommendations for improving patient safety in general practices in England: a qualitative content analysis of free-text responses using the patient reported experiences and outcomes of safety in primary care (PREOS-PC) questionnaire. Health Expect. 2017;20(5):961–972.
- Vehviläinen-Julkunen K, Turpeinen S, Kvist T, et al. Experience of ambulatory cancer care: understanding patients’ perspectives of quality using sentiment analysis. Cancer Nurs. 2021;44(6):E331–8. doi:10.1097/NCC.0000000000000845
- Shu CH, Lee PO, Lan MY, Lee YL. Factors affecting the impact of olfactory loss on the quality of life and emotional coping ability. Rhinology. 2011;49(3):337–341. doi:10.4193/Rhino10.130
- Alt JA, Mace JC, Buniel MC, et al. Predictors of olfactory dysfunction in rhinosinusitis using the brief smell identification test. Laryngoscope. 2014;124(7):E259–E266. doi:10.1002/lary.24587
- Mattos JL, Schlosser RJ, Storck KA, Soler ZM. Understanding the relationship between olfactory-specific quality of life, objective olfactory loss, and patient factors in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7(7):734–740. doi:10.1002/alr.21940
- O’Cathain A, Thomas KJ. “Any other comments?” Open questions on questionnaires - A bane or a bonus to research? BMC Med Res Methodol. 2004;4:25. doi:10.1186/1471-2288-4-25
- Greaves F, Ramirez-Cano D, Millett C, et al. Use of sentiment analysis for capturing patient experience from free-text comments posted online. J Med Internet Res. 2013;15(11):e239. doi:10.2196/jmir.2721
- Dambha-Miller H, Silarova B, Irving G, et al. Patients’ views on interactions with practitioners for type 2 diabetes: a longitudinal qualitative study in primary care over 10 years. Br J Gen Pract. 2018;68(666):e36–e43. doi:10.3399/bjgp17X693917